Talon: Assessing Marqibo's FDA Odds:
SAN MATEO, Calif. (TheStreet) -- An FDA advisory panel convenes March 21 to review Marqibo, a leukemia drug from Talon Therapeutics. A breakdown of what to expect:
What are Marqibo's chances for a positive panel vote?
Small. I won't guarantee a negative vote; there's always a chance the panel could look favorably on the drug, but the odds are against.
...
Click to view a price quote on TLON.
Click to research the Drugs industry.
SAN MATEO, Calif. (TheStreet) -- An FDA advisory panel convenes March 21 to review Marqibo, a leukemia drug from Talon Therapeutics. A breakdown of what to expect:
What are Marqibo's chances for a positive panel vote?
Small. I won't guarantee a negative vote; there's always a chance the panel could look favorably on the drug, but the odds are against.
...
Click to view a price quote on TLON.
Click to research the Drugs industry.
Comments